Concepedia

Suvini Perera

SP

Statistics

Publications

1

Citations

10

H-Index

1

Active since

2024

Affiliations

Immutep (Germany)(Current)

Suvini Perera is an author at Immutep (Germany) specializing in metastatic cancer management, immunotherapy, and targeted therapy.

Publications per year

2024–2024

1

Publications

1

Eftilagimod Alpha (a Soluble LAG-3 Protein) Combined With Pembrolizumab in Second-Line Metastatic NSCLC Refractory to Anti–Programmed Cell Death Protein 1/Programmed Death-Ligand 1-Based Therapy: Final Results from a Phase 2 Study

Matthew Krebs, Martin Förster, Margarita Majem et al. · JTO Clinical and Research Reports · 2024 · 10 citations · Full text

, , +17

1–1 of 1